Your search history is turned on.
Date: April 15, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Nova Scotia, Ontario, Quebec, Saskatchewan
Form 52-109V1 Certification of Annual Filings Venture Issuer Basic Certificate I, Greg Muir, President, Chief Executive Officer and acting Chief Financial Officer, Orbus Pharma Inc., certify the following: 1. Review. I have reviewed the AIF, if any, annual financial statements and annual MD&A, including for greater certainty, all documents and information that are incorporated by ref...
ORBUS PHARMA INC. FORM 51-102F1 MANAGEMENTS DISCUSSION & ANALYSIS FOR THE THREE MONTHS AND YEAR ENDED DECEMBER 31, 2023 This Management Discussion and Analysis (MD&A) of Orbus Pharma Inc. (the Company) provides analysis of the Companys financial results for the three months and year ended December 31, 2023. The following information s...
Date: April 15, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F2 CLASS 2 REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, MUIR, Greg, an officer of the reporting issuer noted below have examined this Form 13-502F2 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonable diligence, the info...
Create participation fee form FORM 13-501F2 CLASS 2 REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, MUIR, Greg, an officer of the reporting issuer noted below have examined this Form 13-501F2 (the Fo rm) being submitted hereunder to the Alberta Securities Commission and certify that to my knowledge, h aving exercised reasonable diligence, the info...
Orbus DEC23 FS - Final Version.pdf BDO Canada LLP, a Canadian limited liability partnership, is a member of BDO International Limited, a UK company limited by guarantee, and forms part of the International BDO network of independent member firms. BDO Canada LLP 903 8th Avenue SW, Suite 620 Calgary AB T2P 0P7 Canada Tel: 403 266 5608 Fax: 403 233 7833 ww...
Date: November 27, 2023 Jurisdictions: Alberta, British Columbia, Manitoba, Nova Scotia, Ontario, Quebec, Saskatchewan
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Greg Muir, President, Chief Executive Officer and acting Chief Financial Officer, Orbus Pharma Inc., certify the following: 1. Review. I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Orbus Pharma Inc. (...
ORBUS PHARMA INC. FORM 51-102F1 MANAGEMENTS DISCUSSION & ANALYSIS - QUARTERLY HIGHLIGHTS FOR THE THREE and NINE MONTHS ENDED SEPTEMBER 30, 2023 This Management's Discussion and Analysis Quarterly Highlights (MD&A) of Orbus Pharma Inc. ("we" or the "Company") has been prepared to provide material updates to the business operations, liquidity and capi...
Orbus Pharma Inc. Q1 2023FS.cvw ORBUS PHARMA INC. Interim Financial Statements Nine Month Period Ended September 30, 2023 (Unaudited) ORBUS PHARMA INC. Index to Interim Financial Statements Nine Month Period Ended September 30, 2023 (Unaudited) Page INTERIM FINANCIAL STATEMENTS Interim Balance Sheet 1 Interim Statement of Loss 2 Interi...